Colgate-Palmolive Company $CL Shares Purchased by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund raised its position in Colgate-Palmolive Company (NYSE:CL) by 2.1% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 312,818 shares of the company’s stock after purchasing an additional 6,521 shares during the period. Illinois Municipal Retirement Fund’s holdings in Colgate-Palmolive were worth $24,719,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Deutsche Bank AG increased its holdings in Colgate-Palmolive by 33.9% during the 4th quarter. Deutsche Bank AG now owns 10,845,857 shares of the company’s stock valued at $857,040,000 after acquiring an additional 2,746,920 shares in the last quarter. GW&K Investment Management LLC lifted its holdings in shares of Colgate-Palmolive by 31.2% in the fourth quarter. GW&K Investment Management LLC now owns 875 shares of the company’s stock valued at $69,000 after purchasing an additional 208 shares in the last quarter. Portfolio Design Labs LLC grew its position in shares of Colgate-Palmolive by 3.6% in the fourth quarter. Portfolio Design Labs LLC now owns 12,513 shares of the company’s stock valued at $989,000 after purchasing an additional 436 shares during the last quarter. Strategic Advocates LLC increased its stake in shares of Colgate-Palmolive by 23.9% during the 4th quarter. Strategic Advocates LLC now owns 1,799 shares of the company’s stock worth $143,000 after purchasing an additional 347 shares in the last quarter. Finally, Alteri Wealth LLC increased its stake in shares of Colgate-Palmolive by 5.2% during the 4th quarter. Alteri Wealth LLC now owns 4,275 shares of the company’s stock worth $338,000 after purchasing an additional 210 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently issued reports on CL. Bank of America reduced their target price on Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a research note on Friday, April 10th. Wells Fargo & Company dropped their price target on Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 8th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $99.00 price objective on shares of Colgate-Palmolive in a research report on Monday, May 4th. Weiss Ratings raised Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, May 4th. Finally, UBS Group boosted their target price on shares of Colgate-Palmolive from $98.00 to $100.00 and gave the company a “buy” rating in a research note on Monday, May 4th. Twelve investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $95.88.

Colgate-Palmolive Price Performance

CL stock opened at $89.91 on Thursday. The stock has a market capitalization of $71.94 billion, a price-to-earnings ratio of 34.98, a price-to-earnings-growth ratio of 4.56 and a beta of 0.33. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33. The stock’s fifty day simple moving average is $86.68 and its 200-day simple moving average is $86.17.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.22 billion. During the same period in the prior year, the firm posted $0.91 EPS. The company’s revenue was up 8.4% on a year-over-year basis. Equities research analysts expect that Colgate-Palmolive Company will post 3.82 EPS for the current year.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.